Combination anti-VEGF, PDT may resolve PCV in eyes with neovascular AMD

The prevalence of polypoidal choroidal vasculopathy was elevated in Caucasian patients with presumed neovascular age-related macular degeneration who responded poorly to ranibizumab monotherapy. In eyes with PCV, combination therapy cleared PCV and stabilized visual acuity, according to a study. The retrospective study included 202 eyes of 180 patients who underwent intravitreal injections of Lucentis 0.5 mg (ranibizumab, Genentech). Patients received three consecutive monthly injections. Those showing evidence of choroidal neovascularization, intraretinal or subretinal fluid, or macular hemorrhage more than 1 month after the last injection were re-treated as needed. The (Read more...)

Full Story →